Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

BRISTOL-MYERS SQUIBB COMPANY

(BMY)
  Report
Delayed Nyse  -  04:00:01 2023-02-06 pm EST
74.53 USD   +0.11%
04:22pBristol-Myers Squibb to Return Development Rights for IL -12 Investigational Immunotherapy Program to Dragonfly
MT
09:51aBristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Conference
AQ
02/03Morgan Stanley Adjusts Price Target on Bristol-Myers Squibb to $62 From $60, Maintains Underweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about BRISTOL-MYERS SQUIBB COMPANY
04:22pBristol-Myers Squibb to Return Development Rights for IL -12 Investigational Immunother..
MT
09:51aBristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Co..
AQ
02/03Morgan Stanley Adjusts Price Target on Bristol-Myers Squibb to $62 From $60, Maintains ..
MT
02/03Atlantic Equities Adjusts Bristol-Myers Squibb's Price Target to $90 From $88, Maintain..
MT
02/03Bristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Co..
BU
02/02Trending: Bristol Myers Squibb Beats 4Q Sales Expectations
DJ
02/02Transcript : Bristol-Myers Squibb Company, Q4 2022 Earnings Call, Feb 02, 202..
CI
02/02Bristol Myers Squibb : Q4 2022 Results Presentation
PU
02/02Bristol Myers Squibb : Q4 2022 Results Presentation (with Appendix)
PU
02/02Tranche Update on Bristol-Myers Squibb Company's Equity Buyback Plan announced on Octob..
CI
02/02Bristol-Myers Squibb Q4 Non-GAAP Earnings, Revenue Decline; Provides 2023 Guidance
MT
02/02Earnings Flash (BMY) BRISTOL MYERS SQUIBB Posts Q4 Revenue $11.41B, vs. Street Est of $..
MT
02/02Earnings Flash (BMY) BRISTOL MYERS SQUIBB Posts Q4 EPS $1.82, vs. Street Est of $1.73
MT
02/02Bristol Myers : Q4 Earnings Snapshot
AQ
02/02Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2022
BU
More most relevant news
All news about BRISTOL-MYERS SQUIBB COMPANY
04:22pBristol-Myers Squibb to Return Development Rights for IL -12 Investigational Immunother..
MT
09:51aBristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Co..
AQ
02/03Morgan Stanley Adjusts Price Target on Bristol-Myers Squibb to $62 From $60, Maintains ..
MT
02/03Atlantic Equities Adjusts Bristol-Myers Squibb's Price Target to $90 From $88, Maintain..
MT
02/03Bristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Co..
BU
02/02Exscientia Says EXS4318 Drug Candidate Has Entered Phase 1 Clinical Trials in US -- Sha..
MT
02/02Trending: Bristol Myers Squibb Beats 4Q Sales Expectations
DJ
02/02Transcript : Bristol-Myers Squibb Company, Q4 2022 Earnings Call, Feb 02, 202..
CI
02/02Bristol Myers Squibb : Q4 2022 Results Presentation
PU
02/02Bristol Myers Squibb : Q4 2022 Results Presentation (with Appendix)
PU
More news
News in other languages on BRISTOL-MYERS SQUIBB COMPANY
04:22pBristol-Myers Squibb rendra à Dragonfly les droits de développement du programme d'immu..
02/02Exscientia déclare que le médicament candidat EXS4318 est entré en phase 1 des essais c..
02/02Bristol-Myers : BPA quasi-stable au 4e trimestre
02/02Baisse du bénéfice non GAAP et du chiffre d'affaires de Bristol-Myers Squibb au 4e trim..
02/02Bristol-Myers Squibb Company fournit des prévisions de résultats pour l'année 2023
02/02Les actions restent généralement fermes avant la cloche, stimulées par les perspectives..
02/02Les perspectives de désinflation et les plateformes méta font grimper les contrats à te..
02/02Marketmind : Fed fillip, double trouble, triple A
01/31Prothena obtient des résultats " positifs " de l'étude de phase 1 sur le traitement à d..
01/31Bristol-Myers Squibb Company annonce la démission du Dr Rupert Vessey, vice-président e..
More news
Analyst Recommendations on BRISTOL-MYERS SQUIBB COMPANY
02/03Morgan Stanley Adjusts Price Target on Bristol-Myers Squibb to $62 From $60, Maintains ..
MT
02/03Atlantic Equities Adjusts Bristol-Myers Squibb's Price Target to $90 From $88, Maintain..
MT
01/31UBS Adjusts Bristol-Myers Squibb Price Target to $77 From $75, Maintains Neutral Rating
MT
01/17Cantor Fitzgerald Starts Bristol-Myers Squibb at Overweight With $95 Price Target
MT
01/03Wells Fargo Ups Price Target on Bristol-Myers Squibb to $78 From $70, Reiterates Equalw..
MT
More recommendations
Press releases
09:51aBristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Co..
AQ
02/03Bristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Co..
BU
02/02Bristol Myers Squibb : Q4 2022 Results Presentation
PU
02/02Bristol Myers Squibb : Q4 2022 Results Presentation (with Appendix)
PU
02/02Bristol Myers Squibb Co : Results of Operations and Financial Condition, Regulation FD Dis..
AQ
More press releases
Upcoming event on BRISTOL-MYERS SQUIBB COMPANY